Abstract
Many previous reports testify to the effectiveness of bleomycin as a drug for the clinical treatment of squamous carcinomata, and some radiotherapists have considered the possibility that an improved therapeutic ratio might be obtained by combined treatment with bleomycin and radiation. This consideration has been stimulated by recent reports of the effects of combined treatment with bleomycin using mammalian cells in vitro. Experiments are described here in which a murine squamous carcinoma has been used to obtain a survival curve for cells of tumours treated in vivo with single doses of bleomycin alone or in combination with radiation given before or after the drug. The survival curve for drug alone was a multicomponent curve with D0 values of 0·1, 0·75 and 2·7 mg/kg. However, the results of the experiments with combined treatment showed no evidence of potentiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Sakamoto, K., Sakka, M. The Effect of Bleomycin and its Combined Effect with Radiation on Murine Squamous Carcinoma Treated in vivo. Br J Cancer 30, 463–468 (1974). https://doi.org/10.1038/bjc.1974.221
Issue Date:
DOI: https://doi.org/10.1038/bjc.1974.221
This article is cited by
-
Die Wirkung von Bleomycin, ICRF 159 und simultaner R�ntgenbestrahlung auf CHO-Fibroblasten
Zeitschrift f�r Krebsforschung und Klinische Onkologie (1977)